Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The HPV Persistence and Progression (PaP) Cohort at Kaiser Permanente Northern California

NCT00435214 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT00435214
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00435214 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The HPV Persistence and Progression (PaP) Cohort at Kaiser Permanente Northern California
Lead sponsor
National Cancer Institute (NCI)
Phase
Observational
Overall status
Completed
Start date
January 29, 2007
Completion date
April 30, 2020
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical neoplasia